Overview
Metastatic malignant neoplasms involving the maxilla represent a complex and challenging clinical scenario, often necessitating multidisciplinary management. These metastases can arise from a variety of primary malignancies, including lung, breast, kidney, and others, each contributing unique challenges in terms of clinical presentation, diagnostic workup, and therapeutic strategies. The maxilla, due to its anatomical location and function, plays a critical role in both mastication and facial aesthetics, making the management of metastatic disease in this region particularly intricate. Surgical interventions, often involving extensive resections like maxillectomy, are frequently required, alongside reconstructive techniques aimed at restoring function and cosmesis. This guideline synthesizes evidence from recent studies to provide a comprehensive overview of the clinical presentation, diagnosis, management, and outcomes associated with metastatic malignant neoplasms to the maxilla.
Clinical Presentation
The clinical presentation of metastatic malignant neoplasms in the maxilla is highly variable and can be influenced by the primary tumor type, the extent of metastasis, and the patient's overall health status. A study encompassing diverse histological types of malignant tumors affecting the maxilla [PMID:36872494] underscores the complexity of these presentations. Common symptoms include pain, swelling, dysphagia, and changes in speech or occlusion, reflecting the anatomical disruption caused by the tumor. In more specific cases, such as the young adult with chondrosarcoma described [PMID:27447167], the clinical picture can be further complicated by the need for aggressive surgical interventions like subtotal maxillectomy combined with orbital exenteration. Such cases highlight the necessity for thorough preoperative assessment to evaluate not only the extent of the primary lesion but also potential involvement of adjacent structures, including the orbit and cranial base. Additionally, patients may present with systemic symptoms related to the primary malignancy or metastatic burden, necessitating a comprehensive evaluation by oncologists and maxillofacial surgeons to tailor appropriate management strategies.
Diagnosis
Diagnosing metastatic disease in the maxilla requires a multifaceted approach, integrating clinical examination with advanced imaging and histopathological confirmation. Imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) are crucial for delineating the extent of the tumor and assessing involvement of adjacent structures [PMID:36872494]. These imaging techniques help in planning surgical approaches and identifying potential reconstructive needs. Histopathological confirmation through biopsy remains essential, often necessitating frozen section analysis to ensure negative margins during surgery. The study by [PMID:36872494] noted that all patients had negative proximal margin frozen section specimens, underscoring the importance of intraoperative assessment for successful surgical clearance. Additionally, positron emission tomography (PET) scans can be valuable in evaluating the extent of metastatic disease and guiding systemic therapy decisions. In clinical practice, a multidisciplinary team approach, including pathologists, radiologists, and oncologists, is vital to ensure accurate diagnosis and staging, which are critical for guiding subsequent management decisions.
Management
The management of metastatic malignant neoplasms in the maxilla typically involves a combination of surgical resection, reconstructive techniques, and systemic therapy, tailored to the individual patient's needs and tumor characteristics. Surgical interventions often include maxillectomy, with various approaches and reconstructive strategies employed to optimize outcomes. A study involving 28 patients who underwent maxillectomy using the Le Fort-Midface (LPM) approach [PMID:36872494] demonstrated the utility of advanced reconstructive methods, including facial-submental artery submental island flaps, extensive pectoralis major myocutaneous flaps, and free anterolateral thigh flaps with titanium mesh. These techniques aim to minimize morbidity and achieve satisfactory functional and aesthetic outcomes. Furthermore, innovative approaches such as computer-guided surgery (CGS) for positioning dental implants in the residual maxilla have been described [PMID:27447167]. This method facilitates the fabrication of a CAD/CAM-designed titanium bar for securing a maxillary obturator, enhancing both stability and retention in complex reconstructions. Strategically placed dental implants not only improve the functional aspects of the obturator but also contribute significantly to patient quality of life by restoring masticatory function and speech clarity.
In cases requiring simultaneous maxillary repositioning and mandibular advancement, rigid fixation has emerged as a superior method compared to skeletal-wire fixation [PMID:2038975]. The study highlighted that rigid fixation significantly reduced maxillary relapse (minimizing movements exceeding 2 mm) and mandibular relapse (6% versus 26% with skeletal-wire fixation), underscoring the importance of stable fixation techniques in achieving long-term stability and functional outcomes. Systemic therapy, including chemotherapy and targeted treatments, often complements surgical interventions, particularly in managing systemic disease burden and preventing further metastasis. The integration of these modalities requires careful coordination among oncologists, surgeons, and reconstructive specialists to optimize patient outcomes.
Complications
Despite advancements in surgical techniques and reconstructive strategies, complications remain a significant concern in the management of metastatic malignant neoplasms affecting the maxilla. Ophthalmic complications, such as orbital involvement or exenteration-related issues, have been reported in a subset of patients, affecting 4 patients in one study [PMID:36872494]. Mandibulotomy complications, including malocclusion and functional deficits, were noted in 7 patients, highlighting the challenges associated with extensive surgical interventions. Additionally, flap failures, though rare, can occur and necessitate prompt intervention to prevent further morbidity. The comparative study by Satrom et al. [PMID:2038975] emphasized that skeletal-wire fixation was associated with a higher incidence of mandibular relapse (26%) compared to rigid fixation (6%), indicating that choice of fixation method significantly influences complication rates and long-term stability. Clinicians must remain vigilant for these potential complications, employing meticulous surgical techniques and close postoperative monitoring to mitigate risks and manage adverse events effectively.
Prognosis & Follow-up
The prognosis for patients with metastatic malignant neoplasms in the maxilla varies widely depending on factors such as primary tumor type, extent of metastasis, and response to treatment. A comprehensive follow-up study [PMID:36872494] reported that at follow-up, 57.1% of patients were alive with no evidence of disease, while 28.6% were alive with disease, and 14.3% succumbed to local recurrence or distant metastasis. Notably, no significant survival differences were observed among different tumor types, suggesting that overall management strategies and systemic control play crucial roles in patient outcomes. Regular follow-up is essential, encompassing clinical examinations, imaging studies, and laboratory assessments to monitor for recurrence and manage systemic disease. Multidisciplinary follow-up clinics involving oncologists, maxillofacial surgeons, and supportive care teams are recommended to address both local and systemic aspects of care comprehensively. Early detection of recurrence or new metastases through vigilant surveillance can significantly influence treatment efficacy and patient survival.
References
1 Chen WL, Zhou B, Huang ZX, Chen R, Hong L, Dong XY. Maxillectomy and Flap Reconstruction of Maxillary Defects After Cancer Ablation Through the Lip-Split Parasymphyseal Mandibulotomy Approach in Patients With Advanced-Stage Maxillary Malignant Tumors. The Journal of craniofacial surgery 2023. link 2 Dawood A, Kalavrezos N, Tanner S. A New Approach to Implant-Based Midface Reconstruction Following Subtotal Maxillectomy. The International journal of oral & maxillofacial implants 2016. link 3 Satrom KD, Sinclair PM, Wolford LM. The stability of double jaw surgery: a comparison of rigid versus wire fixation. American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 1991. link81632-4)
3 papers cited of 4 indexed.